James F. Mattingly Jr - Jan 25, 2024 Form 4 Insider Report for BrightSpring Health Services, Inc. (BTSG)

Role
Title: Executive Vice President and Chief Financial Officer
Signature
/s/ Steven S. Reed, as Attorney-in-Fact
Stock symbol
BTSG
Transactions as of
Jan 25, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 04:15 PM
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTSG Common Stock Award $0 +77.2K +196.57% $0.00 116K Jan 26, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTSG Stock Options (Right to Buy) Award $0 +185K +50% $0.00 554K Jan 25, 2024 Common Stock 185K $6.37 Direct F2
transaction BTSG Stock Options (Right to Buy) Award $0 +28K $0.00 28K Jan 25, 2024 Common Stock 28K $13.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement.
F2 Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.
F3 Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024.

Remarks:

Title: Executive Vice President and Chief Financial Officer